| 000 | 00885 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513105729.0 | ||
| 264 | 0 | _c19970115 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.47.6_suppl_3.137s _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGerlach, M | |
| 245 | 0 | 0 |
_aPharmacology of selegiline. _h[electronic resource] |
| 260 |
_bNeurology _cDec 1996 |
||
| 300 |
_aS137-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAntiparkinson Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aSelegiline _xpharmacokinetics |
| 700 | 1 | _aYoudim, M B | |
| 700 | 1 | _aRiederer, P | |
| 773 | 0 |
_tNeurology _gvol. 47 _gno. 6 Suppl 3 _gp. S137-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.47.6_suppl_3.137s _zAvailable from publisher's website |
| 999 |
_c8951866 _d8951866 |
||